Melphalan toxicity following treatment of retinoblastoma identified by pattern electroretinogram
- 4 November 2022
- journal article
- case report
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 44 (4) , 385-388
Abstract
To describe a patient with retinoblastoma and subsequent maculopathy unrelated to the tumor but related to intra-arterial melphalan documented by pattern electroretinography.Comprehensive ophthalmi...Keywords
Funding Information
- funding
This publication has 11 references indexed in Scilit:
- Integrated Treatment during the Intravitreal Melphalan Era: Concurrent Intravitreal Melphalan and Systemic ChemoreductionOcular Oncology and Pathology, 2018
- Long‐term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan eraPediatric Blood & Cancer, 2017
- ISCEV standard for clinical visual evoked potentials: (2016 update)Documenta Ophthalmologica, 2016
- A review of the literature for intra-arterial chemotherapy used to treat retinoblastomaPediatric Radiology, 2016
- Local and Systemic Toxicity of Intravitreal Melphalan for Vitreous Seeding in RetinoblastomaOphthalmology, 2014
- A Longitudinal Study of Stargardt Disease: Clinical and Electrophysiologic Assessment, Progression, and Genotype CorrelationsAmerican Journal of Ophthalmology, 2013
- Pharmacokinetic Analysis of Melphalan after Superselective Ophthalmic Artery Infusion in Preclinical Models and Retinoblastoma PatientsInvestigative Ophthalmology & Visual Science, 2012
- ERG monitoring of retinal function during systemic chemotherapy for retinoblastomaBritish Journal of Ophthalmology, 2012
- Comparison of ERGs recorded with skin and corneal-contact electrodes in normal children and adultsDocumenta Ophthalmologica, 2004
- Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limbBritish Journal of Cancer, 1994